BioNTech SE - ADR

-9.74 (-3.33%)
Regulatory, Earnings Announcements

Pfizer And Biontech: Positive Trial Results Of COVID-19 Vaccine In Children Of 5 To 11 Years

Published: 09/20/2021 10:56 GMT
BioNTech SE - ADR (BNTX) - Pfizer and Biontech Announce Positive Topline Results From Pivotal Trial of Covid-19 Vaccine in Children 5 to 11 Years.
Results Are First From a Pivotal Trial of Any Covid-19 Vaccine in Children Under 12 Years of Age.
In Participants 5 to 11 Years of Age, Vaccine Was Safe, Well Tolerated and Showed Robust Neutralizing Antibody Responses.companies Plan to Submit These Data to FDA, Ema and Other Regulatory Agencies Around World As Soon As Possible.
Results in Children Under 5 Years of Age Are Expected As Soon As Later This Year.
Revenue is expected to be $5.58 Billion
Adjusted EPS is expected to be $11.43

Next Quarter Revenue Guidance is expected to be $5.12 Billion
Next Quarter EPS Guidance is expected to be $9.98

More details on our Analysts Page.